A SBIR Phase II contract was awarded to Actuated Medical in May, 2020 for $527,554.0 USD from the U.S. Department of Defense and Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense.
Currently, there are no issues on this topic.